.@sangerinstitute latest suggests 1 in 5 with #breastcancer may benefit from PARP inhib, even without #BRCA mutatio… https://t.co/6iyEHEFgkB

.@sangerinstitute latest suggests 1 in 5 with #breastcancer may benefit from PARP inhib, even without #BRCA mutatio… https://t.co/6iyEHEFgkB

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/841334319805267968
via IFTTT